| DxFLEX 10C Clinical Study (NCT05467449) | Beckman Coulter, Inc. | 2022-04-12 |
| Individual Dietary Counseling Based on Taste-tests in Patients With Hematological Cancer in Cytostatic Therapy (NCT05364359) | University of Copenhagen | 2022-03-28 |
| CXCR4-targeted PET/CT Imaging in Hematological Malignancies (NCT05255926) | Zhongnan Hospital | 2022-03-01 |
| SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies (NCT04684108) | Hangzhou Sumgen Biotech Co., Ltd. | 2021-11-04 |
| Use of nMoABs for the Treatment of COVID-19 in Patients With HM. (NCT04932967) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2021-09-30 |
| Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies (NCT05391022) | Constellation Pharmaceuticals | 2021-07-20 |
| Systematic Symptom Identification With Disease Specific PROM to Assess Symptoms of Chronic GVHD in Outpatient Care in Patients Post HSCT (NCT04884204) | Rigshospitalet, Denmark | 2021-04-30 |
| A Mixed Method to Study Adherence to Oral Anticancer Medications in a Multilingual and Multicultural Setting (NCT04613765) | Jules Bordet Institute | 2020-12-01 |
| Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies (NCT04305249) | Antengene Therapeutics Limited | 2020-08-15 |
| Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours (NCT06238336) | Shanxi Bethune Hospital | 2020-06-15 |
| Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 (NCT04347226) | Columbia University | 2020-04-16 |
| Membrane Target Detection for Leukemia Treatment (NCT04841447) | University of Missouri-Columbia | 2020-03-20 |
| CAR-T Cellular Therapy for B Cell Malignancies Involved in CNS (NCT04287309) | Zhejiang University | 2020-02-28 |
| Dual PD-1 and JAK2 Inhibition in Hematological Malignancies (NCT04016116) | NYU Langone Health | 2019-12-01 |
| Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy (NCT04093622) | Fate Therapeutics | 2019-10-04 |
| Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells (NCT04082910) | Chinese PLA General Hospital | 2019-09-15 |
| Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ) (NCT03806712) | Centre Hospitalier Universitaire de Besancon | 2019-04-01 |
| VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies (NCT03885947) | Alla Keyzner | 2019-02-21 |
| MS Detection of Somatic Mutations in Hematological Malignancies (NCT03771079) | University Hospital, Strasbourg, France | 2018-12-01 |
| Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002). (NCT04687982) | Istituto Clinico Humanitas | 2018-11-13 |
| Body Scan Activity on Bone Marrow Transplant Patients and Their Caregivers (NCT03611764) | Washington University School of Medicine | 2018-04-17 |
| Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation (NCT03159702) | Medical College of Wisconsin | 2017-12-08 |
| A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients (NCT03241550) | Astellas Pharma Global Development, Inc. | 2017-10-02 |
| Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics (NCT02828462) | Gustave Roussy, Cancer Campus, Grand Paris | 2016-10-24 |
| Effects of Exercise on Allogeneic Stem Cell Transplant (NCT02900768) | Raewyn Broady | 2016-09-01 |
| HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib (NCT03850366) | Henry Ford Health System | 2016-03-08 |
| Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials (NCT02534649) | Institut Bergonié | 2015-12-01 |
| Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation (NCT02598752) | Memorial Sloan Kettering Cancer Center | 2015-11-01 |
| Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL (NCT02361346) | Molecular Templates, Inc. | 2015-02-01 |
| Prognosis of Hematological Cancer Patient Underwent Mechanical Ventillation (NCT02562105) | Mansoura University | 2015-01-01 |
| Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO (NCT02149329) | Amsterdam UMC, location VUmc | 2014-12-01 |
| Early Antibiotic Discontinuation in FUO (NCT02906254) | University Hospital, Brest | 2014-02-01 |
| The Effect of Special Diets in Hematological Cancer Patients (NCT02880709) | Jens Rikardt Andersen | 2013-11-01 |
| Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation (NCT01853358) | Institut Paoli-Calmettes | 2013-04-01 |
| Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation (NCT01757145) | Rabin Medical Center | 2013-01-01 |
| Effect of Body Mass on Filgrastim Pharmacokinetics (NCT01719432) | Aaron Cumpston, PharmD, BCOP | 2012-12-05 |
| Effect of Body Mass on Acyclovir Pharmacokinetics (NCT01714180) | West Virginia University | 2012-10-01 |
| Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis (NCT01860170) | Corewell Health West | 2012-04-01 |
| A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area (NCT02372357) | Universitaire Ziekenhuizen KU Leuven | 2012-02-01 |
| Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL (NCT01576653) | Robert Krause, MD | 2011-06-01 |
| A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies (NCT01317927) | Spectrum Pharmaceuticals, Inc | 2010-12-01 |
| A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy (NCT00558675) | Mirror Biologics, Inc. | 2010-12-01 |
| Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies (NCT01084252) | Sanofi | 2010-05-11 |
| Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders (NCT00897260) | University of British Columbia | 2009-05-01 |
| Pharmacologic Optimization of Voriconazole (NCT00893555) | Jan-Willem C Alffenaar | 2009-04-01 |
| A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation (NCT00894049) | Institut Paoli-Calmettes | 2002-11-01 |
| Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host (NCT00149032) | Hadassah Medical Organization | 2001-08-01 |
| Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients (NCT00195533) | Wyeth is now a wholly owned subsidiary of Pfizer | 2001-07-01 |